Back to Search
Start Over
Ibrutinib is Effective in Refractory Type II Cryoglobulinemia.
- Source :
-
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2019 Dec; Vol. 19 (12), pp. e629-e632. Date of Electronic Publication: 2019 Sep 03. - Publication Year :
- 2019
- Subjects :
- Adenine analogs & derivatives
Biomarkers
Biopsy
Cryoglobulinemia etiology
Female
Fluorescent Antibody Technique
Humans
Kidney metabolism
Kidney pathology
Middle Aged
Piperidines
Protein Kinase Inhibitors administration & dosage
Protein Kinase Inhibitors adverse effects
Pyrazoles administration & dosage
Pyrazoles adverse effects
Pyrimidines administration & dosage
Pyrimidines adverse effects
Treatment Outcome
Cryoglobulinemia diagnosis
Cryoglobulinemia drug therapy
Protein Kinase Inhibitors therapeutic use
Pyrazoles therapeutic use
Pyrimidines therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 2152-2669
- Volume :
- 19
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Clinical lymphoma, myeloma & leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 31585822
- Full Text :
- https://doi.org/10.1016/j.clml.2019.07.442